Previous studies have shown both CD4+ and CD8+ T cells cooperate synergistically in hMPV eradication during primary infection, with the CD4+ T cells contributing more to clinical disease and lung pathology and CD8+ T cells contributing significantly to viral clearance (26). Here, CD4 is linked to infection.